- Home
- XBIO vs PPBT Comparison
XBIO vs PPBT Comparison
Compare XBIO & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIO
- PPBT
- Stock Information
- Founded
- XBIO N/A
- PPBT 2010
- Country
- XBIO United States
- PPBT Israel
- Employees
- XBIO 4
- PPBT N/A
- Industry
- XBIO Biotechnology: Pharmaceutical Preparations
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- XBIO Health Care
- PPBT Health Care
- Exchange
- XBIO Nasdaq
- PPBT Nasdaq
- Market Cap
- XBIO 6.3M
- PPBT 6.7M
- IPO Year
- XBIO N/A
- PPBT N/A
- Fundamental
- Price
- XBIO $4.06
- PPBT $3.78
- Analyst Decision
- XBIO Hold
- PPBT Strong Buy
- Analyst Count
- XBIO 1
- PPBT 2
- Target Price
- XBIO N/A
- PPBT $126.50
- AVG Volume (30 Days)
- XBIO 22.9K
- PPBT 2.7M
- Earning Date
- XBIO 11-12-2024
- PPBT 11-15-2024
- Dividend Yield
- XBIO N/A
- PPBT N/A
- EPS Growth
- XBIO N/A
- PPBT N/A
- EPS
- XBIO N/A
- PPBT N/A
- Revenue
- XBIO $2,523,427.00
- PPBT N/A
- Revenue This Year
- XBIO N/A
- PPBT N/A
- Revenue Next Year
- XBIO N/A
- PPBT N/A
- P/E Ratio
- XBIO N/A
- PPBT N/A
- Revenue Growth
- XBIO 7.15
- PPBT N/A
- 52 Week Low
- XBIO $2.78
- PPBT $2.00
- 52 Week High
- XBIO $5.20
- PPBT $20.60
- Technical
- Relative Strength Index (RSI)
- XBIO 52.07
- PPBT 48.29
- Support Level
- XBIO $3.92
- PPBT $3.56
- Resistance Level
- XBIO $4.27
- PPBT $4.22
- Average True Range (ATR)
- XBIO 0.25
- PPBT 1.40
- MACD
- XBIO -0.04
- PPBT -0.07
- Stochastic Oscillator
- XBIO 38.45
- PPBT 4.11
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.